
News|Articles|December 3, 2025
Digital Expression Control with GPEx® Lightning: Enabling Complex Biologics in CHO Cells
Author(s)Catalent
This scientific poster showcases how GPEx® Lightning enables precise, digital control of gene expression for complex biologics. By leveraging targeted integration into ~200 Dock sites and a single optimized construct, developers can fine-tune gene ratios for co-expression of enzymes, cofactors, and multi-chain proteins. Learn how this approach streamlines screening, boosts titers, and shortens timelines—even for products with unknown stoichiometry.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Genentech Expands RNAi Pipeline Through Global Licensing Deal
2
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
3
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
4
Industry Outlook 2026: How AI and Payer Pressure Impact Biopharma R&D (Part 1)
5